$CGC
Canopy Growth Corp

2024 Q3 Form 10-Q Financial Statement

#000095017024094330 Filed on August 09, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $62.99M $66.21M
YoY Change -9.49% -39.1%
Cost Of Revenue $41.15M $43.18M
YoY Change -10.86% -57.99%
Gross Profit $21.84M $23.03M
YoY Change -6.78% 287.92%
Gross Profit Margin 34.67% 34.78%
Selling, General & Admin $41.73M $47.97M
YoY Change -27.57% -47.43%
% of Gross Profit 191.09% 208.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $5.682M
YoY Change -49.91%
% of Gross Profit 24.67%
Operating Expenses $67.78M $52.14M
YoY Change 122.72% -46.4%
Operating Profit -$45.94M -$29.11M
YoY Change 555.67% -68.13%
Interest Expense $21.28M $21.14M
YoY Change -22.39% -34.31%
% of Operating Profit
Other Income/Expense, Net -$85.31M -$93.89M
YoY Change -33.53% -282.32%
Pretax Income -$131.2M -$123.0M
YoY Change -3.02% 208.7%
Income Tax $302.0K $6.194M
% Of Pretax Income
Net Earnings -$128.3M -$127.1M
YoY Change -58.62% 233.51%
Net Earnings / Revenue -203.67% -192.02%
Basic Earnings Per Share -$1.48 -$1.60
Diluted Earnings Per Share -$1.48 -$1.60
COMMON SHARES
Basic Shares Outstanding 84.86M 76.20M
Diluted Shares Outstanding 86.83M 79.24M

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $194.9M
YoY Change -65.87%
Cash & Equivalents $228.4M $192.2M
Short-Term Investments $2.766M
Other Short-Term Assets $4.351M $7.446M
YoY Change -37.11% 24.06%
Inventory $90.09M $84.52M
Prepaid Expenses $11.94M $9.764M
Receivables $36.52M $43.51M
Other Receivables $1.377M $2.784M
Total Short-Term Assets $391.7M $357.8M
YoY Change -20.67% -59.49%
LONG-TERM ASSETS
Property, Plant & Equipment $303.2M $315.0M
YoY Change -12.44% -20.29%
Goodwill $44.53M $43.37M
YoY Change -46.9% -48.61%
Intangibles $95.39M $98.96M
YoY Change -35.88% -45.91%
Long-Term Investments $136.4M $150.7M
YoY Change -75.49% -75.9%
Other Assets $19.08M $22.56M
YoY Change 0.64% 15.61%
Total Long-Term Assets $840.7M $928.4M
YoY Change -28.42% -28.98%
TOTAL ASSETS
Total Short-Term Assets $391.7M $357.8M
Total Long-Term Assets $840.7M $928.4M
Total Assets $1.232B $1.286B
YoY Change -26.13% -41.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $18.36M $25.49M
YoY Change -19.19% -55.71%
Accrued Expenses $51.29M
YoY Change -31.99%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $137.9M $2.457M
YoY Change 176.03% -99.03%
Total Short-Term Liabilities $281.3M $166.6M
YoY Change 43.33% -63.07%
LONG-TERM LIABILITIES
Long-Term Debt $415.9M $558.5M
YoY Change -34.11% -29.5%
Other Long-Term Liabilities $25.46M $28.22M
YoY Change -71.49% -71.36%
Total Long-Term Liabilities $441.4M $586.7M
YoY Change -38.74% -34.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $281.3M $166.6M
Total Long-Term Liabilities $441.4M $586.7M
Total Liabilities $722.7M $753.3M
YoY Change -21.34% -43.91%
SHAREHOLDERS EQUITY
Retained Earnings -$10.59B -$10.46B
YoY Change 5.63% 7.69%
Common Stock $11.11B $11.01B
YoY Change 2.93% 4.22%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $509.7M $532.9M
YoY Change
Total Liabilities & Shareholders Equity $1.232B $1.286B
YoY Change -26.13% -41.28%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$128.3M -$127.1M
YoY Change -58.62% 233.51%
Depreciation, Depletion And Amortization $5.682M
YoY Change -49.91%
Cash From Operating Activities -$51.78M
YoY Change -65.17%
INVESTING ACTIVITIES
Capital Expenditures $3.920M
YoY Change 95.22%
Acquisitions
YoY Change
Other Investing Activities -$29.10M
YoY Change -385.55%
Cash From Investing Activities -$33.03M
YoY Change -123.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $11.84M
YoY Change -89.99%
Cash From Financing Activities 105.8M
YoY Change -179.46%
NET CHANGE
Cash From Operating Activities -51.78M
Cash From Investing Activities -33.03M
Cash From Financing Activities 105.8M
Net Change In Cash 21.86M
YoY Change -115.21%
FREE CASH FLOW
Cash From Operating Activities -$51.78M
Capital Expenditures $3.920M
Free Cash Flow -$55.70M
YoY Change -63.03%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 dei Amendment Flag
AmendmentFlag
false
CY2024Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001737927
CY2024Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2024Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
CY2024Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2025-09-30
CY2024Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1
CY2024Q2 us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.canopygrowth.com/20240630#ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
CY2023Q2 us-gaap Discontinued Operation Gain Loss On Disposal Statement Of Income Or Comprehensive Income Extensible Enumeration
DiscontinuedOperationGainLossOnDisposalStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://www.canopygrowth.com/20240630#ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
CY2024Q2 dei Document Type
DocumentType
10-Q
CY2024Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q2 dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
CY2024Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q2 dei Entity File Number
EntityFileNumber
001-38496
CY2024Q2 dei Entity Registrant Name
EntityRegistrantName
Canopy Growth Corporation
CY2024Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
CY2024Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
1 Hershey Drive
CY2024Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Smiths Falls
CY2024Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
ON
CY2024Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
K7A 0A8
CY2024Q2 dei City Area Code
CityAreaCode
855
CY2024Q2 dei Local Phone Number
LocalPhoneNumber
558-9333
CY2024Q2 dei Security12b Title
Security12bTitle
Common shares, no par value
CY2024Q2 dei Trading Symbol
TradingSymbol
CGC
CY2024Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q2 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2024Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q2 dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
84856023
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192156000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170300000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
2766000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
33161000
CY2024Q2 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
7691000
CY2024Q1 us-gaap Restricted Investments Current
RestrictedInvestmentsCurrent
7310000
CY2024Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
50889000
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
51847000
CY2024Q2 us-gaap Inventory Net
InventoryNet
84518000
CY2024Q1 us-gaap Inventory Net
InventoryNet
77292000
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
8038000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19773000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23232000
CY2024Q2 us-gaap Assets Current
AssetsCurrent
357793000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
371180000
CY2024Q2 us-gaap Equity Method Investments
EquityMethodInvestments
150669000
CY2024Q2 cgc Other Financial Assets
OtherFinancialAssets
297865000
CY2024Q1 cgc Other Financial Assets
OtherFinancialAssets
437629000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
315022000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320103000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
98956000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
104053000
CY2024Q2 us-gaap Goodwill
Goodwill
43368000
CY2024Q1 us-gaap Goodwill
Goodwill
43239000
CY2024Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22555000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24126000
CY2024Q2 us-gaap Assets
Assets
1286228000
CY2024Q1 us-gaap Assets
Assets
1300330000
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
25488000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
28673000
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
51293000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
54039000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2457000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
103935000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
87361000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48068000
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
166599000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
234715000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
558489000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
493294000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28217000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
71814000
CY2024Q2 us-gaap Liabilities
Liabilities
753305000
CY2024Q1 us-gaap Liabilities
Liabilities
799823000
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
80999437
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80999437
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
91115501
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
91115501
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
8393936000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
8244301000
CY2024Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2617703000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2602148000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-21548000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-16051000
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10457168000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10330030000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
532923000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
500368000
CY2024Q1 us-gaap Minority Interest
MinorityInterest
139000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
532923000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
500507000
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1286228000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1300330000
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
75783000
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
88644000
CY2024Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
9571000
CY2023Q2 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
12386000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66212000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76258000
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
43181000
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62496000
CY2024Q2 us-gaap Gross Profit
GrossProfit
23031000
CY2023Q2 us-gaap Gross Profit
GrossProfit
13762000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47968000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62763000
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4151000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3717000
CY2024Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20000
CY2023Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1934000
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
52139000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
68414000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-29108000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-54652000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-93889000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46101000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-122997000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8551000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6194000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2018000
CY2024Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-129191000
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-10569000
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
2053000
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-31292000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-127138000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-41861000
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest
-3740000
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-127138000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38121000
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.63
CY2024Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.63
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.19
CY2023Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.19
CY2024Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
0.03
CY2024Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
0.03
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.5
CY2023Q2 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.5
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.6
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.6
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.69
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79243020
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79243020
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55045936
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
55045936
CY2024Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-129191000
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-10569000
CY2023Q2 us-gaap Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment Attributable To Parent
OtherComprehensiveIncomeLossFinancialLiabilityFairValueOptionAfterTaxAndReclassificationAdjustmentAttributableToParent
14178000
CY2024Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-768000
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7160000
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-768000
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
7018000
CY2024Q2 cgc Comprehensive Income Loss Net Of Tax From Continuing Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-129959000
CY2023Q2 cgc Comprehensive Income Loss Net Of Tax From Continuing Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-3551000
CY2024Q2 cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
2053000
CY2023Q2 cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsIncludingPortionAttributableToNoncontrollingInterest
-31292000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-127906000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34843000
CY2023Q2 cgc Comprehensive Income Loss Net Of Tax From Discontinued Operations Attributable To Noncontrolling Interests And Redeemable Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxFromDiscontinuedOperationsAttributableToNoncontrollingInterestsAndRedeemableNoncontrollingInterest
-3740000
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-127906000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31103000
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
500507000
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46291000
CY2024Q2 cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Share Issue Costs
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndShareIssueCosts
-3189000
CY2024Q2 cgc Exercise Of Warrants
ExerciseOfWarrants
7563000
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4151000
CY2024Q2 cgc Adjustments To Additional Paid In Capital Extinguishment Of Promissory Note And Issuance Of Exchangeable Shares
AdjustmentsToAdditionalPaidInCapitalExtinguishmentOfPromissoryNoteAndIssuanceOfExchangeableShares
74098000
CY2024Q2 cgc Disposal Group Including Discontinued Operation Issuance Of Common Shares
DisposalGroupIncludingDiscontinuedOperationIssuanceOfCommonShares
22711000
CY2024Q2 cgc Warrant Value Issuance Of Warrants
WarrantValueIssuanceOfWarrants
8697000
CY2024Q2 cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-127906000
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
532923000
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
760022000
CY2023Q2 cgc Adjustments To Additional Paid In Capital Other Issuances Of Common Shares And Warrants Value
AdjustmentsToAdditionalPaidInCapitalOtherIssuancesOfCommonSharesAndWarrantsValue
118803000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3716000
CY2023Q2 cgc Stock Issued During Period Value Redemption Of Redeemable Noncontrolling Interest
StockIssuedDuringPeriodValueRedemptionOfRedeemableNoncontrollingInterest
-193000
CY2023Q2 cgc Comprehensive Income Loss Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeLossNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-34843000
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
847505000
CY2024Q2 us-gaap Profit Loss
ProfitLoss
-127138000
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-41861000
CY2024Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
2053000
CY2023Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-31292000
CY2024Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-129191000
CY2023Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-10569000
CY2024Q2 us-gaap Depreciation
Depreciation
5682000
CY2023Q2 us-gaap Depreciation
Depreciation
10689000
CY2024Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5348000
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6422000
CY2024Q2 cgc Share Based Compensation Including Amounts Recorded In Selling General And Administrative Expenses
ShareBasedCompensationIncludingAmountsRecordedInSellingGeneralAndAdministrativeExpenses
4151000
CY2023Q2 cgc Share Based Compensation Including Amounts Recorded In Selling General And Administrative Expenses
ShareBasedCompensationIncludingAmountsRecordedInSellingGeneralAndAdministrativeExpenses
3717000
CY2024Q2 cgc Gain Loss On Asset Impairment And Restructuring
GainLossOnAssetImpairmentAndRestructuring
-86000
CY2023Q2 cgc Gain Loss On Asset Impairment And Restructuring
GainLossOnAssetImpairmentAndRestructuring
-10582000
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6194000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2018000
CY2024Q2 cgc Non Cash Fair Value Adjustments And Charges Related To Settlement Of Long Term Debt
NonCashFairValueAdjustmentsAndChargesRelatedToSettlementOfLongTermDebt
79793000
CY2023Q2 cgc Non Cash Fair Value Adjustments And Charges Related To Settlement Of Long Term Debt
NonCashFairValueAdjustmentsAndChargesRelatedToSettlementOfLongTermDebt
-68455000
CY2024Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-668000
CY2023Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20410000
CY2024Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7008000
CY2023Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2237000
CY2024Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
185000
CY2023Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-404000
CY2024Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5911000
CY2023Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-18015000
CY2024Q2 cgc Increase Decrease In Other Non Cash Foreign Currency
IncreaseDecreaseInOtherNonCashForeignCurrency
11407000
CY2023Q2 cgc Increase Decrease In Other Non Cash Foreign Currency
IncreaseDecreaseInOtherNonCashForeignCurrency
24839000
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-51780000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-106219000
CY2023Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-42452000
CY2024Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51780000
CY2023Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-148671000
CY2024Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3920000
CY2023Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1946000
CY2024Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
14000
CY2023Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
304000
CY2024Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
4926000
CY2023Q2 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
83143000
CY2024Q2 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-30022000
CY2023Q2 us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-72153000
CY2024Q2 cgc Payments For Proceeds From Divestiture Of Interest In Deconsolidation Of Subsidiaries And Affiliates
PaymentsForProceedsFromDivestitureOfInterestInDeconsolidationOfSubsidiariesAndAffiliates
6968000
CY2024Q2 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
28103000
CY2023Q2 us-gaap Proceeds From Sale And Collection Of Loans Receivable
ProceedsFromSaleAndCollectionOfLoansReceivable
367000
CY2024Q2 cgc Payments For Proceeds From Other Financial Assets
PaymentsForProceedsFromOtherFinancialAssets
95335000
CY2023Q2 cgc Payments For Proceeds From Other Financial Assets
PaymentsForProceedsFromOtherFinancialAssets
472000
CY2023Q2 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
10556000
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-43186000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
142385000
CY2024Q2 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
10157000
CY2023Q2 us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
189000
CY2024Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33029000
CY2023Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
142574000
CY2024Q2 cgc Proceeds From Issuance Of Common Shares And Warrants
ProceedsFromIssuanceOfCommonSharesAndWarrants
53854000
CY2024Q2 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
68255000
CY2024Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
11836000
CY2023Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
118277000
CY2024Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4498000
CY2023Q2 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-14833000
CY2024Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
105775000
CY2023Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-133110000
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
890000
CY2023Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4534000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
21856000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-143741000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
170300000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
677007000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
192156000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
533266000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
9314000
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
0
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations
9816000
CY2024Q2 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
2091000
CY2023Q2 us-gaap Proceeds From Interest Received
ProceedsFromInterestReceived
7831000
CY2023Q2 cgc Income Taxes Received
IncomeTaxesReceived
245000
CY2024Q2 us-gaap Interest Paid Net
InterestPaidNet
18199000
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
30410000
CY2024Q2 cgc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-217000
CY2023Q2 cgc Increase Decrease Capital Expenditures Incurred But Not Yet Paid
IncreaseDecreaseCapitalExpendituresIncurredButNotYetPaid
-635000
CY2024Q1 cgc Private Placement Unit Offering Completed
PrivatePlacementUnitOfferingCompleted
35000000
CY2024Q2 cgc Promissory Note
PromissoryNote
100000000
CY2024Q2 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:4.52%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates. Financial statement areas that require significant judgements and estimates are as follows:</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Allowance for credit losses </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">- The assessment involves judgement and incorporates estimates of loss based on available information relevant to considering the collectability and includes consideration of economic and business conditions, default trends and other internal and external factors. The amount is subject to change based on experience and new information which could result in outcomes that require adjustment to the carrying amounts affecting future periods.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Inventory reserves</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - The Company records inventory reserves based on the Company’s estimated forecast of product demand, production requirements, market conditions and regulatory environment. Actual losses may differ from management’s estimates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Estimated useful lives, impairment considerations, and amortization of property, plant and equipment and intangible assets</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - Amortization of capital and intangible assets is dependent upon estimates of useful lives based on management’s judgment.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Goodwill and indefinite lived intangible asset impairment testing requires management to make estimates in the impairment testing model. On at least an annual basis, the Company tests whether goodwill and indefinite lived intangible assets are impaired. The reporting unit's fair value is determined using a discounted future cash flow model, which incorporate assumptions regarding future events, specifically future cash flows, growth rates and discount rates.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Impairment of long-lived assets is influenced by judgment in defining an asset group and determining the indicators of impairment, and estimates used to measure impairment losses.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Legal proceedings</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - Judgement is used in determining the probability of incurring a loss in addition to determining the estimated amount. Amounts recorded are based on management’s judgement and actual amounts recorded may not be realized.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Fair value measurement of financial instruments</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - The use of various valuation approaches described in Note 23 may involve uncertainties and determinations based on the Company’s judgment and any value estimated from these techniques may not be realized or realizable.</span></p><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Consolidation of variable interest entities</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> - The determination of whether the Company is the primary beneficiary of a variable interest entity requires significant judgement. The assessment requires a qualitative analysis of power and benefits of the variable interest entity.</span></p>
CY2024Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On December 13, 2023, the Company announced that the Company’s board of directors (the “Board”) had approved the consolidation of the Company’s issued and outstanding common shares on the basis of one post-consolidation common share for every 10 pre-consolidation common shares (the “Share Consolidation”).
CY2022Q4 cgc Percentage Ownership Of Wholly Owned Subsidiaries
PercentageOwnershipOfWhollyOwnedSubsidiaries
1
CY2024Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20000
CY2023Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1934000
CY2024Q2 us-gaap Cash
Cash
119406000
CY2024Q1 us-gaap Cash
Cash
115427000
CY2024Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
72750000
CY2024Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
54873000
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
192156000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
170300000
CY2024Q2 us-gaap Short Term Investments
ShortTermInvestments
2766000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
33161000
CY2024Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
2766000
CY2024Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
33161000
CY2024Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43514000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
44943000
CY2024Q2 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
3053000
CY2024Q1 us-gaap Value Added Tax Receivable
ValueAddedTaxReceivable
2517000
CY2024Q2 us-gaap Interest Receivable Current
InterestReceivableCurrent
1538000
CY2024Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
876000
CY2024Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
2784000
CY2024Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3511000
CY2024Q2 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
50889000
CY2024Q1 us-gaap Accounts Notes And Loans Receivable Net Current
AccountsNotesAndLoansReceivableNetCurrent
51847000
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9856000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9903000
CY2024Q2 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
18201000
CY2024Q1 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
18872000
CY2024Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
35785000
CY2024Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
31367000
CY2024Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
30532000
CY2024Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
27053000
CY2024Q2 us-gaap Inventory Net
InventoryNet
84518000
CY2024Q1 us-gaap Inventory Net
InventoryNet
77292000
CY2024Q2 us-gaap Inventory Write Down
InventoryWriteDown
690000
CY2023Q2 us-gaap Inventory Write Down
InventoryWriteDown
3545000
CY2024Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
9764000
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6621000
CY2024Q2 cgc Prepaid Deposits Current
PrepaidDepositsCurrent
1999000
CY2024Q1 cgc Prepaid Deposits Current
PrepaidDepositsCurrent
2365000
CY2024Q2 cgc Prepaid Inventory Current
PrepaidInventoryCurrent
564000
CY2024Q1 cgc Prepaid Inventory Current
PrepaidInventoryCurrent
757000
CY2024Q2 us-gaap Other Assets Current
OtherAssetsCurrent
7446000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
13489000
CY2024Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19773000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23232000
CY2024Q1 cgc Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
437629000
CY2024Q2 cgc Other Financial Assets Additions
OtherFinancialAssetsAdditions
308459000
CY2024Q2 cgc Changes In Other Financial Asset Fair Value Through Profit Or Loss
ChangesInOtherFinancialAssetFairValueThroughProfitOrLoss
813000
CY2024Q2 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4120000
CY2024Q2 cgc Other Financial Assets Other
OtherFinancialAssetsOther
453156000
CY2024Q2 cgc Other Noncurrent Financial Asset
OtherNoncurrentFinancialAsset
297865000
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
418083000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
418283000
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
103061000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
98180000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
315022000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320103000
CY2024Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
199978000
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
70275000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
199588000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
75453000
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
98956000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
104053000
CY2023Q1 us-gaap Goodwill
Goodwill
85563000
CY2024 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
42081000
CY2024 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-243000
CY2024Q1 us-gaap Goodwill
Goodwill
43239000
CY2024Q2 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
129000
CY2024Q2 us-gaap Goodwill
Goodwill
43368000
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21649000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
21468000
CY2024Q2 cgc Taxes And Government Fees Payable Current
TaxesAndGovernmentFeesPayableCurrent
10648000
CY2024Q1 cgc Taxes And Government Fees Payable Current
TaxesAndGovernmentFeesPayableCurrent
10519000
CY2024Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3597000
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
5849000
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
15399000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16203000
CY2024Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
51293000
CY2024Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
54039000
CY2024Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
916000
CY2024Q1 us-gaap Other Long Term Debt
OtherLongTermDebt
1143000
CY2024Q2 us-gaap Senior Notes
SeniorNotes
560946000
CY2024Q1 us-gaap Senior Notes
SeniorNotes
597229000
CY2024Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
2457000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
103935000
CY2024Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
558489000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
493294000
CY2021Q1 cgc Debt Instrument Discounted Price
DebtInstrumentDiscountedPrice
930000
CY2018Q4 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.06
CY2018Q4 cgc Proceeds From Credit Facility
ProceedsFromCreditFacility
100000000
CY2020Q3 cgc Cancellation Of Debt
CancellationOfDebt
63500000
CY2018Q4 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2025-09-10
CY2018Q4 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.85
CY2020Q3 cgc Accretion Rate
AccretionRate
0.1106
CY2023Q3 cgc Principal Amount Of Accretion Debentures
PrincipalAmountOfAccretionDebentures
10434000
CY2020Q3 cgc Debt Instrument Monthly Interest Rate Percentage
DebtInstrumentMonthlyInterestRatePercentage
0.01
CY2022Q2 cgc Debt Instrument Shares Acquired Percentage
DebtInstrumentSharesAcquiredPercentage
1
CY2020Q3 cgc Conversion Of Outstanding Debentures Description
ConversionOfOutstandingDebenturesDescription
In addition, the Company may force conversion of the Supreme Debentures outstanding with 30 days’ notice if the daily volume weighted average trading price of the Company’s common shares is greater than $385.90 for any 10 consecutive trading days. The Company, Supreme Cannabis and the Trustee entered into a further supplemental indenture whereby the Company agreed to guarantee the obligations of Supreme Cannabis pursuant to the Supreme Debentures and the Accretion Debentures.
CY2024Q2 cgc Principal Payments Of Accretion Debentures
PrincipalPaymentsOfAccretionDebentures
677000
CY2024Q2 cgc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
43159000
CY2024Q2 cgc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
19426000
CY2024Q2 cgc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
62585000
CY2024Q1 cgc Operating And Finance Lease Liability Current
OperatingAndFinanceLeaseLiabilityCurrent
15173000
CY2024Q1 cgc Operating And Finance Lease Liability Noncurrent
OperatingAndFinanceLeaseLiabilityNoncurrent
55597000
CY2024Q1 cgc Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
70770000
CY2024Q2 cgc Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
26755000
CY2024Q2 cgc Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
4397000
CY2024Q2 cgc Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
31152000
CY2024Q1 cgc Acquisition Consideration Related Liabilities Current
AcquisitionConsiderationRelatedLiabilitiesCurrent
12809000
CY2024Q1 cgc Acquisition Consideration Related Liabilities Noncurrent
AcquisitionConsiderationRelatedLiabilitiesNoncurrent
10558000
CY2024Q1 cgc Acquisition Consideration Related Liabilities
AcquisitionConsiderationRelatedLiabilities
23367000
CY2024Q2 cgc Refund Liability Current
RefundLiabilityCurrent
4201000
CY2024Q2 cgc Refund Liability
RefundLiability
4201000
CY2024Q1 cgc Refund Liability Current
RefundLiabilityCurrent
4169000
CY2024Q1 cgc Refund Liability
RefundLiability
4169000
CY2024Q2 cgc Settlement Liabilities And Other Current
SettlementLiabilitiesAndOtherCurrent
13246000
CY2024Q2 cgc Settlement Liabilities And Other Non Current
SettlementLiabilitiesAndOtherNonCurrent
4394000
CY2024Q2 cgc Settlement Liabilities And Other
SettlementLiabilitiesAndOther
17640000
CY2024Q1 cgc Settlement Liabilities And Other Current
SettlementLiabilitiesAndOtherCurrent
15917000
CY2024Q1 cgc Settlement Liabilities And Other Non Current
SettlementLiabilitiesAndOtherNonCurrent
5659000
CY2024Q1 cgc Settlement Liabilities And Other
SettlementLiabilitiesAndOther
21576000
CY2024Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
87361000
CY2024Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
28217000
CY2024Q2 us-gaap Other Liabilities
OtherLiabilities
115578000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
48068000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
71814000
CY2024Q1 us-gaap Other Liabilities
OtherLiabilities
119882000
CY2023Q2 cgc Number Of Equity Financing
NumberOfEquityFinancing
0
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10451457
CY2024Q1 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
9.12
CY2024Q1 cgc Warrant Value
WarrantValue
2610519000
CY2024Q2 cgc Number Of Whole Warrants On Issuance Of Warrants
NumberOfWholeWarrantsOnIssuanceOfWarrants
3350430
CY2024Q2 cgc Average Exercise Price On Issuance Of Warrants
AverageExercisePriceOnIssuanceOfWarrants
16.18
CY2024Q2 cgc Warrant Value Issuance Of Warrants
WarrantValueIssuanceOfWarrants
8697000
CY2024Q2 cgc Number Of Whole Warrants On Exercise Of Warrants
NumberOfWholeWarrantsOnExerciseOfWarrants
1145760
CY2024Q2 cgc Average Exercise Price On Warrant Exercised
AverageExercisePriceOnWarrantExercised
6.61
CY2024Q2 cgc Warrant Value Exercise Of Warrants
WarrantValueExerciseOfWarrants
-2702000
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12656127
CY2024Q2 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
11.29
CY2024Q2 cgc Warrant Value
WarrantValue
2616514000
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12819305
CY2023Q1 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
580.4
CY2023Q1 cgc Warrant Value
WarrantValue
2581788000
CY2023Q2 cgc Number Of Whole Warrants On Expiry Of Warrants
NumberOfWholeWarrantsOnExpiryOfWarrants
0
CY2023Q2 cgc Average Exercise Price On Warrant Expiry
AverageExercisePriceOnWarrantExpiry
0
CY2023Q2 cgc Warrant Value Expiry Of Warrants
WarrantValueExpiryOfWarrants
0
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12819305
CY2023Q2 cgc Warrants Average Exercise Price
WarrantsAverageExercisePrice
580.4
CY2023Q2 cgc Warrant Value
WarrantValue
2581788000
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1281815
CY2023Q3 cgc Extended Period Of Option From Grant Date
ExtendedPeriodOfOptionFromGrantDate
P10Y
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
0
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2883922
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.01
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
760436
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.38
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
83959
CY2024Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
129.04
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3560399
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
55.88
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3560399
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y7M9D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1176266
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M24D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
55.88
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
125.91
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
70.01
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
312.68
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0366
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0383
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.17
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.83
CY2024Q2 cgc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.20
CY2023Q2 cgc Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0.21
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.05
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.8
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66212000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76258000
CY2024Q2 cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
1200000
CY2023Q2 cgc Allowance For Estimated Returns And Price Adjustments
AllowanceForEstimatedReturnsAndPriceAdjustments
937000
CY2024Q2 cgc Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
4201000
CY2024Q1 cgc Liability For Estimated Sales Returns And Price Adjustments
LiabilityForEstimatedSalesReturnsAndPriceAdjustments
4169000
CY2024Q2 cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
-813000
CY2023Q2 cgc Other Financial Assets Fair Value Adjustment
OtherFinancialAssetsFairValueAdjustment
-65118000
CY2024Q2 cgc Equity Method Investments Fair Value Adjustment
EquityMethodInvestmentsFairValueAdjustment
-75970000
CY2023Q2 cgc Debt Fair Value Adjustment
DebtFairValueAdjustment
1852000
CY2024Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
26755000
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-6776000
CY2024Q2 cgc Gain Loss And Charges Related To Settlement Of Debt
GainLossAndChargesRelatedToSettlementOfDebt
22119000
CY2023Q2 cgc Gain Loss And Charges Related To Settlement Of Debt
GainLossAndChargesRelatedToSettlementOfDebt
-5291000
CY2024Q2 cgc Interest Income
InterestIncome
2058000
CY2023Q2 cgc Interest Income
InterestIncome
7831000
CY2024Q2 us-gaap Interest Expense
InterestExpense
21143000
CY2023Q2 us-gaap Interest Expense
InterestExpense
32185000
CY2024Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
33000
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-139000
CY2024Q2 cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
4956000
CY2023Q2 cgc Other Miscellaneous Non Operating Income Expense Net
OtherMiscellaneousNonOperatingIncomeExpenseNet
2139000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-93889000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46101000
CY2024Q2 cgc Debentures Bear Interest Rate Per Annum
DebenturesBearInterestRatePerAnnum
0.061
CY2024Q2 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66212000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76258000
CY2024Q2 us-gaap Gross Profit
GrossProfit
23031000
CY2023Q2 us-gaap Gross Profit
GrossProfit
13762000
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47968000
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
62763000
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
4151000
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3717000
CY2024Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-20000
CY2023Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1934000
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-29108000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-54652000
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-93889000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46101000
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-122997000
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8551000
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66212000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
76258000
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
315022000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
320103000
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-094330-index-headers.html Edgar Link pending
0000950170-24-094330-index.html Edgar Link pending
0000950170-24-094330.txt Edgar Link pending
0000950170-24-094330-xbrl.zip Edgar Link pending
cgc-20240630.htm Edgar Link pending
cgc-20240630.xsd Edgar Link pending
cgc-ex10_13.htm Edgar Link pending
cgc-ex31_1.htm Edgar Link pending
cgc-ex31_2.htm Edgar Link pending
cgc-ex32_1.htm Edgar Link pending
cgc-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R112.htm Edgar Link pending
R113.htm Edgar Link pending
R114.htm Edgar Link pending
R115.htm Edgar Link pending
R116.htm Edgar Link pending
cgc-20240630_htm.xml Edgar Link completed
R117.htm Edgar Link pending
R118.htm Edgar Link pending
R119.htm Edgar Link pending
R12.htm Edgar Link pending
R120.htm Edgar Link pending
R121.htm Edgar Link pending
R122.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable